Compile Data Set for Download or QSAR
Report error Found 43 Enz. Inhib. hit(s) with all data for entry = 50015952
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162822(1-(1-{3-[3-(3,4-Dichloro-phenyl)-5-methanesulfonyl...)
Affinity DataIC50: 10nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50152992(1-[1-(3-{4-[Bis-(4-fluoro-phenyl)-methyl]-piperazi...)
Affinity DataIC50: 20nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50152989(Carbamic acid 2-[5-carbamoyl-3-(4-iodo-phenyl)-4,5...)
Affinity DataIC50: 20nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162858(6-Chloro-1-(1-{3-[5-methanesulfonyl-3-(4-trifluoro...)
Affinity DataIC50: 30nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162843(3-(1-{2-Hydroxy-3-[5-methanesulfonyl-3-(4-trifluor...)
Affinity DataIC50: 30nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162828(1-(1-(3-(3-(3,4-dichlorophenyl)-5-(methylsulfonyl)...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162853(6-Chloro-1-(1-{3-[3-(4-chloro-3-methyl-phenyl)-5-m...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162824(1-(1-{3-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162838(1-(1-{3-[5-Methanesulfonyl-3-(4-trifluoromethyl-ph...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162847(1-(1-{2-Hydroxy-3-[5-methanesulfonyl-3-(4-trifluor...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50152985(1-{3-[4-(2-Cyano-phenyl)-piperazin-1-yl]-2-hydroxy...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162857(1-(1-{3-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,...)
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162839(1-(1-{3-[3-(4-Chloro-3-methyl-phenyl)-5-methanesul...)
Affinity DataIC50: 60nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162832(6-Chloro-1-(1-{2-hydroxy-3-[5-methanesulfonyl-3-(4...)
Affinity DataIC50: 60nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162848(5-Chloro-3-(1-{2-hydroxy-3-[5-methanesulfonyl-3-(4...)
Affinity DataIC50: 80nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162834(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 80nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162823(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 90nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162826(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 90nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162842(1-(1-{3-[5-Acetyl-3-(4-trifluoromethyl-phenyl)-4,5...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162825(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162851([3-(1-{3-[5-Methanesulfonyl-3-(4-trifluoromethyl-p...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162844(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162827(5-chloro-1-methyl-3-(1-(3-(5-(methylsulfonyl)-3-(4...)
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162835(1-(1-{3-[5-Acetyl-3-(4-trifluoromethyl-phenyl)-4,5...)
Affinity DataIC50: 110nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162829(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 110nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50152988(2-(4-{3-[5-Acetyl-3-(4-iodo-phenyl)-4,5,6,7-tetrah...)
Affinity DataIC50: 120nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162821(1-(1-{3-[5-Acetyl-3-(4-iodo-phenyl)-4,5,6,7-tetrah...)
Affinity DataIC50: 120nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162837(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 120nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162831(1-(1-{3-[5-Acetyl-3-(4-trifluoromethoxy-phenyl)-4,...)
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162845(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162836(1-(1-{3-[3-(4-Bromo-phenyl)-5-methanesulfonyl-4,5,...)
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162820(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162846(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 140nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162856(5-Chloro-3-(1-{3-[3-(3,4-dichloro-phenyl)-5-methan...)
Affinity DataIC50: 150nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162854(1-(1-{(R)-3-[5-Acetyl-3-(4-trifluoromethyl-phenyl)...)
Affinity DataIC50: 180nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162833(1-(1-{(S)-3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)...)
Affinity DataIC50: 190nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162841(1-(1-{(S)-3-[5-Acetyl-3-(4-trifluoromethyl-phenyl)...)
Affinity DataIC50: 200nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162855(1-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetra...)
Affinity DataIC50: 210nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162850(1-(1-{3-[5-Acetyl-3-(4-iodo-phenyl)-4,5,6,7-tetrah...)
Affinity DataIC50: 230nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162852(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 310nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162830(1-(1-{(R)-3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)...)
Affinity DataIC50: 350nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162849(1-(1-{3-[5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetr...)
Affinity DataIC50: 460nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Johnson and Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50162840(1-(1-{3-[5-Acetyl-3-(4-chloro-3-methyl-phenyl)-4,5...)
Affinity DataIC50: 500nMAssay Description:Inhibitory concentration against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed